These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11641780)

  • 1. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.
    Meuwissen R; Linn SC; van der Valk M; Mooi WJ; Berns A
    Oncogene; 2001 Oct; 20(45):6551-8. PubMed ID: 11641780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice.
    Lyons SK; Meuwissen R; Krimpenfort P; Berns A
    Cancer Res; 2003 Nov; 63(21):7042-6. PubMed ID: 14612492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
    Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma.
    Hammoud Z; Tan B; Badve S; Bigsby RM
    Endocr Relat Cancer; 2008 Jun; 15(2):475-83. PubMed ID: 18509000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of lung cancer progression by bexarotene in mouse models.
    Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
    Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung tumorigenesis associated with erb-B-2 and erb-B-3 overexpression in human erb-B-3 transgenic mice is enhanced by methylnitrosourea.
    Zhou H; Liu L; Lee K; Qin X; Grasso AW; Kung HJ; Willis JE; Kern J; Wagner T; Gerson SL
    Oncogene; 2002 Dec; 21(57):8732-40. PubMed ID: 12483526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras activation generates an inflammatory response in lung tumors.
    Ji H; Houghton AM; Mariani TJ; Perera S; Kim CB; Padera R; Tonon G; McNamara K; Marconcini LA; Hezel A; El-Bardeesy N; Bronson RT; Sugarbaker D; Maser RS; Shapiro SD; Wong KK
    Oncogene; 2006 Mar; 25(14):2105-12. PubMed ID: 16288213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The simultaneous induction of tumorigenesis and Cre-loxP recombination in mice.
    Sakahara M; Ohkawara H; Nakao K; Yokozaki H; Aiba A
    Kobe J Med Sci; 2009 Mar; 54(6):E279-89. PubMed ID: 19628969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
    Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.
    Puyol M; Martín A; Dubus P; Mulero F; Pizcueta P; Khan G; Guerra C; Santamaría D; Barbacid M
    Cancer Cell; 2010 Jul; 18(1):63-73. PubMed ID: 20609353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
    Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
    Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
    Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
    Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient in vitro and in vivo excision of floxed sequences with a high-capacity adenoviral vector expressing Cre recombinase.
    Badorf M; Edenhofer F; Dries V; Kochanek S; Schiedner G
    Genesis; 2002 Jul; 33(3):119-24. PubMed ID: 12124944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mouse models of K-ras-initiated oncogenesis].
    Barrière C; Marjou FE; Louvard D; Robine S
    Bull Cancer; 2009 Dec; 96 Suppl():S5-14. PubMed ID: 20034865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.